The COVID-19 surge in Indonesia: what we learned and what to expect

Tenda, Eric Daniel; Asaf, Moses Mazmur; Pradipta, Ariel; Kumaheri, Meutia Ayuputeri; Susanto, Anindya Pradipta

doi:10.1183/20734735.0146-2021

Cited by 6 publications

(5 citation statements)

References 16 publications

(15 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It caused a massive surge in daily new confirmed COVID-19 cases, leading to an increase in the hospital bed occupancy rate (BOR). 9 On December 15, 2021, the identification of the first Omicron variant of SARS-CoV-2 in Indonesia sparked interest. Given the experience from other countries, the Delta variant will most likely be displaced by Omicron as the dominant variant in Indonesia.…”

Section: Discussionmentioning

confidence: 99%

Clinical Characteristic of Different SARS-CoV-2 Variants in South Kalimantan, Indonesia: A Case Study

Haryati

Rahmawaty

Isa

et al. 2023

AMJ

View full text Add to dashboard Cite

Background: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has undergone various mutations of Corona Virus Disease 2019 (COVID-19). The World Health Organization (WHO) has designated B.1.617.2 (Delta) and B.1.1.529 (Omicron) as variants of concern (VOC). Since clinical features and epidemiological characteristics of patients infected with SARS-CoV-2 variants remain largely unknown, especially in Indonesia, this study aimed to identify the clinical characteristics of COVID-19 patients from South Kalimantan, Indonesia.Methods: Data from medical records of COVID-19 patients at Ulin General Hospital Banjarmasin from June 2021 to February 2022 were randomly extracted, containing demographic data, comorbidities, and laboratory data, as well as the type of virus. Results: In total, 32 patients were included, 9 were infected with delta, 14 with probable omicrons, and 9 with non-VOC. Patients in the probable Omicron group were significantly older than other groups (median age 64 years old, range 54–73 years; p=0.049), had hypertension as the dominant comorbidity (85.7%; p=0.039), the onset appeared slightly earlier (median 3 days; range 2-3 days, p=0.062), with no anosmia symptom (p=0.006). Critical illness predominated and mostly survived in all variants but was not statistically significant (p=0.590 and 0.726, respectively). The three variants showed similarities in laboratory findings; hence, statistical analysis suggested that the leucocytes differed significantly (p=0.020).Conclusions: Patients with the likely Omicron variant are much older, have hypertension as their main comorbidity, do not have any symptoms of anosmia, and have higher leukocyte counts compared to other variants.

show abstract

Section: Discussionmentioning

confidence: 99%

Clinical Characteristic of Different SARS-CoV-2 Variants in South Kalimantan, Indonesia: A Case Study

Haryati

Rahmawaty

Isa

et al. 2023

AMJ

View full text Add to dashboard Cite

show abstract

“…Earlier and more widespread transmission in Oecusse during Timor-Leste's first large wave may be related to its close proximity to Indonesia and the large case burden there. 5 Targeted vaccination efforts towards vulnerable individuals, including older people, should be maintained.…”

Section: Discussionmentioning

confidence: 99%

The use of residual serum samples to perform serological surveillance of severe acute respiratory syndrome coronavirus 2 in Dili and regional areas of Timor-Leste

Sarmento

Ico

Sheridan

et al. 2022

Transactions of the Royal Society of Tropical Medicine and Hygiene

View full text Add to dashboard Cite

Background Lack of access to diagnostic testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can limit disease surveillance in remote areas. Serological surveillance can indicate the true extent and distribution of infections in such settings. Methods This study monitored SARS-CoV-2 seroprevalence in residual serum samples salvaged from laboratories at five healthcare facilities across Timor-Leste from March to October 2021. Results Seroprevalence increased from 8.3% to 87.0% during the study period. Potential immunity gaps were identified among children aged 0–15 y (who had not been eligible for vaccination) and individuals aged >60 y. Conclusions Efforts to vaccinate vulnerable individuals including older people should be maintained. Residual serum samples can be analysed to give local, contemporary information about the extent and distribution of antibodies to infections, especially SARS-CoV-2, in areas where epidemiological information is limited.

show abstract

“…These factors differed from the original scale's "fear of social interaction" and "illness anxiety" factors, which time differences in data collection could mainly cause. Approximately nineteen months spanned between the original scale's trial stage, which was conducted in February and March 2020 before India's nationwide lockdown was implemented (Gettleman & Schultz, 2020), in comparison with the current adaptation's trial stage, which was conducted in October and November 2021 after the Indonesian government had issued large-scale social restrictions since the beginning of the year while a rapid acceleration of active Covid-19 cases severely burdened the nation's healthcare system by June until August 2021 (Tenda et al, 2021). In these two time frames, the public focus shifted from intangible fears of social interaction and illness anxiety about an emerging disease, mainly told through mass media and initial social distancing, into fears of contagion and pandemic-related information or thoughts as the death toll rose and the virus underwent various variants (Centers for Disease Control and Prevention, 2023;Team Verywell Health, 2023).…”

Section: Factorial Validitymentioning

confidence: 99%

Adapting and Validating the Covid-19 Anxiety Scale (CAS-7) in Indonesia

Thiefanee,

Kumalasari

2024

JP3I

View full text Add to dashboard Cite

There has been a lack of anxiety assessments designed explicitly in the context of COVID-19, particularly screening tools that are easy to understand for diverse demographics and easily administered to accommodate Indonesia’s large population. CAS-7 has proven to be an effectively administrable, reliable, and valid assessment to measure pandemic‑related anxiety among the Indian population. This study aimed to adapt and validate CAS-7 to provide a reliable and valid screening tool to timely identify citizens of Indonesia suffering from pandemic-related anxiety and assign them suitable interventions. There were 1,121 subjects from 29 provinces participated in the study. Factorial validity was tested with Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA) in JASP 15.0.0. while convergent validity, test-retest reliability, and internal reliability were tested with Pearson product-moment correlation coefficient, intraclass correlation coefficient, and Cronbach’s alpha in SPSS 25. The adaptation of CAS-7 has proven to be a satisfactory, reliable, and valid screening tool for identifying citizens of Indonesia suffering from pandemic-related anxiety, with changes made in item arrangement and factor interpretation.

show abstract

The COVID-19 surge in Indonesia: what we learned and what to expect

Abstract: ERSpublicationsThrough the implementation of a test and trace system, disciplined public health measures, the acceleration of vaccinations, and a genome surveillance programme, LMICs such as Indonesia can prevent future outbreaks and survive the COVID-19 pandemic. https://bit.ly/3JBBSie

Cited by 6 publications

References 16 publications

Clinical Characteristic of Different SARS-CoV-2 Variants in South Kalimantan, Indonesia: A Case Study

Clinical Characteristic of Different SARS-CoV-2 Variants in South Kalimantan, Indonesia: A Case Study

The use of residual serum samples to perform serological surveillance of severe acute respiratory syndrome coronavirus 2 in Dili and regional areas of Timor-Leste

Adapting and Validating the Covid-19 Anxiety Scale (CAS-7) in Indonesia

Contact Info

Product

Resources

About